Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ubiquitin-specific protease 11 promotes partial epithelial-to-mesenchymal transition by deubiquitinating the epidermal growth factor receptor during kidney fibrosis
Yingfeng Shi, Min Tao, Hui Chen, et al.
Kidney International (2022) Vol. 103, Iss. 3, pp. 544-564
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Ubiquitin–proteasome system as a target for anticancer treatment—an update
Yeon‐Jung Kim, Yeonjoo Lee, H. Y. Shin, et al.
Archives of Pharmacal Research (2023) Vol. 46, Iss. 7, pp. 573-597
Closed Access | Times Cited: 27
The role of epithelial cells in fibrosis: Mechanisms and treatment
Liuyi Luo, Wei Zhang, Siyao You, et al.
Pharmacological Research (2024) Vol. 202, pp. 107144-107144
Open Access | Times Cited: 9
Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2‐dependent mechanism
Wei‐Jian Ni, Hong Zhou, Hao Lu, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 8
Open Access | Times Cited: 17
Caspase-11/GSDMD contributes to the progression of hyperuricemic nephropathy by promoting NETs formation
Fan Wu, Caiming Chen, Guo Lin, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 6
TGF‑β/Smad signaling in chronic kidney disease: Exploring post‑translational regulatory perspectives (Review)
Jianchun Li, Yuanxia Zou, Jiraporn Kantapan, et al.
Molecular Medicine Reports (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 6
The SGLT2 inhibitor dapagliflozin ameliorates renal fibrosis in hyperuricemic nephropathy
Hongtu Hu, Weiwei Li, Yiqun Hao, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 8, pp. 101690-101690
Open Access | Times Cited: 6
X-linked ubiquitin-specific peptidase 11 (USP11) increases susceptibility to Cushing’s disease in women
Tao Zhang, Yanting Liu, Fang Liu, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access
Autophagy Related 5 Promotes Mitochondrial Fission and Inflammation via HSP90‐HIF‐1α‐Mediated Glycolysis in Kidney Fibrosis
Yan Hu, Jinqing Li, Hui Chen, et al.
Advanced Science (2025)
Open Access
Fasudil attenuates oxidative stress-induced partial epithelial-mesenchymal transition of tubular epithelial cells in hyperuricemic nephropathy via activating Nrf2
Yun Cao, Yanni Wang, Weiwei Li, et al.
European Journal of Pharmacology (2024) Vol. 975, pp. 176640-176640
Open Access | Times Cited: 4
Bone Marrow Mesenchymal Stem Cell‐Derived Exosomal USP10 Alleviates Cerebral Ischemia‐Reperfusion Injury via Stabilizing SLC7A11 by Deubiquitination
Nannuan Liu, Yue Xu, Genshan Gao, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 4
Closed Access
USP25 inhibits renal fibrosis by regulating TGFβ-SMAD signaling pathway in Ang II-induced hypertensive mice
Ying‐Yong Zhao, Xi Chen, Yimin Lin, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 6, pp. 166713-166713
Open Access | Times Cited: 10
Podocyte OTUD5 alleviates diabetic kidney disease through deubiquitinating TAK1 and reducing podocyte inflammation and injury
Ying‐Yong Zhao, Shijie Fan, Hong Zhu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Inhibition of EGFR attenuates EGF-induced activation of retinal pigment epithelium cell via EGFR/AKT signaling pathway
Yu-Sheng Zhu, Hui-Hui Zhang, Tong Wang, et al.
International Journal of Ophthalmology (2024) Vol. 17, Iss. 6, pp. 1018-1027
Open Access | Times Cited: 2
Status and role of the ubiquitin–proteasome system in renal fibrosis
Yizhen Chen, Rong Dai, Meng Cheng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117210-117210
Open Access | Times Cited: 2
Astragalus membranaceus and its monomers treat peritoneal fibrosis and related muscle atrophy through the AR/TGF-β1 pathway
Li Sheng, Jinyi Sun, Liyan Huang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
GRP/GRPR signaling pathway aggravates hyperuricemia-induced renal inflammation and fibrosis via ABCG2-dependent mechanisms
Haolu Sun, He-ge Bian, Xuemei Liu, et al.
Biochemical Pharmacology (2023) Vol. 218, pp. 115901-115901
Closed Access | Times Cited: 5
USP38 exacerbates atrial inflammation, fibrosis, and susceptibility to atrial fibrillation after myocardial infarction in mice
Yang Gong, Tingting Yu, Wei Shuai, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Demethyleneberberine Alleviates Pulmonary Fibrosis through Disruption of USP11 Deubiquitinating GREM1
Chuang Ge, Mengsheng Huang, Yanhong Han, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 279-279
Open Access | Times Cited: 1
Crosstalk of ubiquitin system and non-coding RNA in fibrosis
Huamin Zhang, Yutong Zhou, Canhua Jiang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 10, pp. 3802-3822
Open Access | Times Cited: 1
Targeting Neuraminidase 4 Attenuates Kidney Fibrosis in Mice
Ping‐Ting Xiao, Jin‐Hua Hao, Yu‐Jia Kuang, et al.
Advanced Science (2024) Vol. 11, Iss. 39
Open Access | Times Cited: 1
Renal Fibrosis: SIRT1 Still of Value
Huailiang Wu, Zhen Qiu, Liyan Wang, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 1942-1942
Open Access | Times Cited: 1
OTUD6A in tubular epithelial cells mediates angiotensin II-induced kidney injury by targeting STAT3
Xiaoyu Sun, Shuhong Chen, Ying Zhao, et al.
AJP Cell Physiology (2023) Vol. 326, Iss. 2, pp. C400-C413
Closed Access | Times Cited: 3
Targeted therapy based on ubiquitin-specific proteases, signalling pathways and E3 ligases in non-small-cell lung cancer
Yuchen Yang, Canjun Zhao, Zhao-Feng Jin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Luteolin blocks the ROS/PI3K/AKT pathway to inhibit mesothelial-mesenchymal transition and reduce abdominal adhesions
Yiwei Ren, Li Gan, Enmeng Li, et al.
European Journal of Pharmacology (2023) Vol. 964, pp. 176272-176272
Open Access | Times Cited: 2
Mechanisms of norcantharidin against renal tubulointerstitial fibrosis
Qin-Su Yun, Yuxin Bao, Jie-Bing Jiang, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 2, pp. 263-272
Closed Access
Page 1 - Next Page

Scroll to top